Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-12-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
2017年第二次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of the 2017 second extraordinary general meeting (EGM) of shareholders of a company. It details the legal compliance of the meeting's call, attendance, and voting results. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. It is not an annual report, interim report, earnings release, or any financial report. It is also not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's legality. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories.
2017-12-08 Chinese
2017年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2017 second extraordinary shareholders' meeting of 中粮生物化学（安徽）股份有限公司. It details the meeting date, attendance, voting results on proposals, and includes a legal opinion confirming the legality and validity of the meeting and voting process. There is no financial data or report content, only the official voting results and meeting procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2114 characters) and it is not an announcement of a report publication but the actual voting results. Therefore, the correct classification is DVA with high confidence.
2017-12-08 Chinese
关于重大资产重组停牌进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring and the continuation of stock trading suspension due to this restructuring. It references multiple previous announcements about the suspension and restructuring process, indicating ongoing updates rather than a final report. The document is relatively short (1428 characters) and focuses on regulatory compliance and disclosure of the suspension status and risk warnings. It does not contain financial statements or detailed financial analysis. Therefore, it is not an Annual Report, Interim Report, or detailed financial filing. Instead, it fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about the status of a major asset restructuring and trading suspension progress.
2017-12-06 Chinese
关于召开2017年第二次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2017 second extraordinary general meeting of shareholders for 中粮生物化学（安徽）股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), proposals to be voted on, registration methods, and proxy voting instructions. There is no financial data, earnings information, or management discussion of results. The document is not a report itself but an announcement and instructions related to a shareholder meeting. It does not contain voting results, so it is not a Declaration of Voting Results. It is not a proxy solicitation statement either, as it does not solicit votes but informs about the meeting and voting process. The content fits best with the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices and procedural details for the meeting.
2017-12-05 Chinese
关于筹划重大资产重组停牌期满申请继续停牌公告（更新后）
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the continuation of a trading suspension due to a planned major asset restructuring. It references previous announcements about the suspension and states that the restructuring plan is still under negotiation and not finalized. The document includes details about the transaction parties, the nature of the restructuring, and shareholder information prior to suspension. It does not contain actual financial statements or detailed financial analysis but is an update on the status of a major asset restructuring and the related stock suspension. The document length is 3239 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it relates to a significant corporate financing and restructuring event and the stock suspension related to it.
2017-12-01 Chinese
关于筹划重大资产重组停牌期满申请继续停牌更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to a previous announcement about the continuation of a trading suspension due to a major asset restructuring plan. It provides corrected details on the top 10 shareholders' holdings before the suspension. The document does not contain financial statements, management discussion, or detailed financial data. It is primarily an announcement correcting previously disclosed shareholder information related to a capital event (asset restructuring). The document length is short (2891 characters) and it is an announcement correcting a prior notice, not a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-12-01 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.